ArticleJournal of hepatology2015

Serum-based tracking of de novo initiated liver cancer progression reveals early immunoregulation and response to therapy.

Jeff J Subleski et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.